新研究找到开发阿尔茨海默病药物的新靶点

Core Insights - An international study involving Sweden's Karolinska Institute has discovered that two types of receptors in the brain can regulate the degradation process of beta-amyloid protein, which is closely associated with Alzheimer's disease [1] Group 1 - The study highlights the potential role of specific brain receptors in managing beta-amyloid levels, which could have implications for Alzheimer's disease treatment [1]